Author

R. Wegmann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:experimental assay· 2 Organism:human· 2 Assay:multiome· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1

Frequent Co-Authors

B. Snijder· 2 shared J. Mena· 2 shared A. Aloia· 1 shared A. Bileck· 1 shared A. Dzung· 1 shared A. Irmisch· 1 shared A. Leitner· 1 shared A. Mukherjee· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. Snijder

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Long-term history dependence of growth rates of E. coli after nutrient shifts

D. Christodoulou, A. Mukherjee, R. Wegmann, A. Pagano, V. Sharma, S. M. Linker, Y.-F. Chang, J. S. Palme, U. Sauer, M. Basan

This study shows that E. coli growth rates on carbon source combinations depend on prior growth conditions, persisting for 15 generations and involving the transcription factor Mlc.

bioRxiv · Aug 22, 2023 · PreprintMicrobiology

ROS induction as a strategy to target persister cancer cells with low metabolic activity in NRAS mutated melanoma

O. M. Eichhoff, C. I. Stoffel, J. Kaesler, L. Briker, P. Turko, G. Karsai, N. Zila, V. Paulitschke, P. F. Cheng, A. Leitner, A. Bileck, N. Zamboni, A. Irmisch, Z. Balazs, A. Tastanova, , M. Levesque

The paper identifies ROS induction as a strategy to target MEK-inhibitor resistant NRAS-mutated melanoma cells by exploiting their quiescent metabolic state and elevated baseline ROS levels.

bioRxiv · Oct 19, 2022 · PreprintCancer Biology

Targeting tumour-intrinsic neural vulnerabilities of glioblastoma

S. Lee, T. Weiss, M. Buehler, J. Mena, Z. Lottenbach, R. Wegmann, M. Sun, M. Bihl, B. Augustynek, S. Baumann, S. Goetze, A. van Drogen, P. Pedrioli, D. Kirschenbaum, F. Vasella, , B. Snijder

This study identifies neural vulnerabilities in glioblastoma by analyzing patient samples and model systems, revealing drug targets and pathways that can be exploited for treatment.

bioRxiv · Oct 7, 2022 · PreprintCancer Biology